The SAGES scoring model leads to personalized treatment via the combination of TACE, TKIs and ICIs for unresectable hepatocellular carcinoma

Background and aimsTranscatheter chemoembolization (TACE) combined with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) shows promising efficacy in treating unresectable hepatocellular carcinoma (uHCC), but the specific patient population that would benefit most from this r...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Hesheng Lin, Xueyao Wang, Jianhong Zhong, Ning Peng, Shaoping Liu, Fanjian Zeng, Wenfeng Li, Ze Su, Junjie Ou, Peisheng Wu, Hongbing Yao, Shuqun Li
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2026-04-01
Serija:	Frontiers in Immunology
Teme:	immune checkpoint inhibitor overall survival progression-free survival sages score transarterial chemoembolization tyrosine kinase inhibitor
Online dostop:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1802427/full
Oznake:	Označite Brez oznak, prvi označite!